
Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.
A panel discussion of the FDA’s Drug Supply Chain Security Act (DSCSA) stabilization policy
By
Date
November 17, 2023
Read time: 1 minute
By: McKesson Health Systems Editorial Team
Recently, Scott Mooney, Vice President of Distribution Operations at McKesson, participated in a Drug Topics Total Pharmacy Summit panel discussion of the FDA’s Drug Supply Chain Security Act (DSCSA) stabilization policy, which delays some facets of DSCSA implementation to November 2024. Watch the free video here, available until February 10, 2024.
Click to learn how McKesson helps health systems achieve more.